Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prevent Health Care International is a Canadian healthcare and medical device company focused on ambulatory cardiac monitoring and related digital monitoring services. The company developed and owned the my-CAM cardiac event monitor and the my-CARDIA software and monitoring service platform, which were described as FDA 510(k)-cleared and CE-certified cardiac monitoring products. Its business centered on providing physicians, cardiologists, and healthcare providers with remote cardiac diagnostic and monitoring solutions. Public materials also indicate expansion efforts into the United States and Asia-Pacific markets through affiliated entities and distributors. In 2020, CB Scientific acquired the operating business assets of Prevent Health Care International, after which the legacy company appears to have remained as a corporate entity while its core operating assets were transferred.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prevent Health Care International.